The University of Glasgow, Scotland has developed a cancer test to improve research into the disease and boost the number of participants in clinical trials. The new trials include a suite of affordable solid tumor and blood cancer tests designed to be used in the routine healthcare worldwide. The Glasgow-based team hopes that it will help scientists in their effort to discover what makes cancer resistant to chemotherapy drugs.
The lead investigator is professor Andrew Biankin, a regius professor of surgery at the University of Glasgow and director of the Glasgow Precision Oncology Laboratory (GPOL), said “The Glasgow Cancer Tests were created so that ultimately every patient could have access to the latest treatments and clinical trials.
Andrew Biankin, a regius professor of surgery at the University of Glasgow and director of the Glasgow Precision Oncology Laboratory (GPOL)
Call to Action: Interested in learning more? Are you based in the Glasgow area? Follow the link to Professor Biankin.